Recruiting

TEACH-HIV

Sponsor:

UCLA

Code:

NCT05642858

Conditions

HIV

Human Immunodeficiency Virus

Cardiovascular Diseases

Atherosclerosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Digital Educational Messaging

Study Details

Brief summary:

The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).

Conditions

HIV

Human Immunodeficiency Virus

Cardiovascular Diseases

Atherosclerosis

Study ID

NCT05642858

Start date

Mar 12, 2023

Status verified date

Jun, 2025

Completion date

Jul 1, 2026

Anticipated

Primary completion date

Dec 1, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • HIV positive
  • At least 40 years of age
  • English-speaking

Exclusion Criteria:

  • Existing clinical atherosclerotic cardiovascular disease (ASCVD)
  • Pregnant
  • Unwilling/unable to provide informed consent
  • Does not own a smartphone

Study Design

Enrollment

260 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

experimental: Intervention Arm

The intervention arm will receive education about HIV and heart disease risk via mobile phone text messages for up to 6 months. They will receive the text messages 3-5 times per week. The messages will include information about HIV and risk of heart disease and information about how to reduce heart disease risk. The intervention arm will also receive brief monthly surveys via a digital research platform.

no intervention: Control Arm

The control arm will not receive the educational text messages. They will receive brief monthly surveys via a digital research platform.

Interventions

Digital Educational Messaging

Education via mobile phone text messages for up to 6 months.

Primary outcome measure

  • Proportion of participants with controlled blood pressure [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Megan McLaughlin, MD, MPH

628-206-8037teachhiv@ucsf.edu

Locations

Zuckerberg San Francisco General Hospital

Recruiting

San Francisco, California, United States, 94110

Contacts

Megan McLaughlin, MD, MPH

teachhiv@ucsf.edu

University of California San Francisco

Recruiting

San Francisco, California, United States, 94115

Contacts

Megan Mclaughlin, MD, MPH

teachhiv@ucsf.edu

More Information

Sponsor

University of California, San Francisco

Last update posted

Jun 8, 2025

Last verified

Jun, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2025-06-08.